-
F169293-5gFmoc-(S)-2-(2-propenyl)Ala-OH
-
F464273-1gFmoc-(S)-2-(5-azidopentane)Ala-OH
-
F464273-250mgFmoc-(S)-2-(5-azidopentane)Ala-OH
-
F350682-1gFmoc-(S,S)-[Pro-Leu]-spirolactame is an Fmoc protected leucine derivative that is potentially useful for proteomics studies and solid phase peptide synthesis techniques. Leucine is one of the more simple amino acids - an isobutyl group as the side
-
F350682-250mgFmoc-(S,S)-[Pro-Leu]-spirolactame is an Fmoc protected leucine derivative that is potentially useful for proteomics studies and solid phase peptide synthesis techniques. Leucine is one of the more simple amino acids - an isobutyl group as the side
-
F350480-1gFmoc-1(1-Boc-piperidin-4-yl)-DL-glycine is an Fmoc protected glycine derivative useful for proteomics studies and solid phase peptide synthesis techniques. Glycine is the simplest, and least sterically hindered of the amino acids, which confers a
-
F350480-250mgFmoc-1(1-Boc-piperidin-4-yl)-DL-glycine is an Fmoc protected glycine derivative useful for proteomics studies and solid phase peptide synthesis techniques. Glycine is the simplest, and least sterically hindered of the amino acids, which confers a
-
F338855-100mgFmoc-1,2-cis-ACHC-OH
-
F338855-1gFmoc-1,2-cis-ACHC-OH
-
F338855-500mgFmoc-1,2-cis-ACHC-OH
-
F478809-1gDescriptionBuilding block for the incorporation of 1-methylhistidine by Fmoc SPPS.Fmoc-1-methyl-L-histidine Novabiochem®. CAS 202920-22-7, molar mass 391.42 g/mol.
-
F478809-250mgDescriptionBuilding block for the incorporation of 1-methylhistidine by Fmoc SPPS.Fmoc-1-methyl-L-histidine Novabiochem®. CAS 202920-22-7, molar mass 391.42 g/mol.